Brief: Orchard Therapeutics Announces Departure Of Chief Commercial Officer
13/09/2019 12:15
Sept 13 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS ANNOUNCES DEPARTURE OF CHIEF
COMMERCIAL
OFFICER
* ORCHARD THERAPEUTICS PLC - CHIEF COMMERCIAL OFFICER JASON
MEYENBURG IS LEAVING COMPANY EFFECTIVE TODAY TO TAKE ON A CHIEF
EXECUTIVE ROLE IN INDUSTRY.
* ORCHARD THERAPEUTICS PLC - CEO MARK ROTHERA WILL ASSUME
GLOBAL
COMMERCIAL LEADERSHIP RESPONSIBILITIES
Source text for Eikon: ID:nGNX4jp5PZ
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln